La série Réalités Industrielles publie trimestriellement des dossiers thématiques sur des sujets importants pour le développement industriel et économique. Piloté par un spécialiste du secteur sous l’égide du Comité de rédaction de la série, chaque dossier présente une large gamme de points de vue complémentaires, en faisant appel à des auteurs issus à la fois de l’enseignement et de la recherche, de l’entreprise, de l’administration ainsi que du monde politique et associatif. Voir la gouvernance de la série

 
 
Numéros précédents

Rechercher :

 

Réalités Industrielles

2017
2016
Années depuis 1985
 

Gérer & Comprendre

2017
2016
Toutes les années
 
Gérer & Comprendre -
English language online edition
2017
2016
 
Responsabilité & Environnement
2017
2016
Toutes les années
 

La Gazette de la société

et des techniques

2017
2016

Toutes les années

 
Le Club des Annales des Mines

Toutes les années

 

Histoire des Ingénieurs
des Mines

Documents de synthèse
Directeurs, professeurs,
anciens élèves des Ecoles des mines
Les principaux textes législatifs ou règlementaires
Biographies relatives à des ingénieurs des mines décédés
Composition du corps des ingénieurs
Autres documents sur les mines, carrières, géologie.
 
La Lettre des Annales des Mines
2017
Toutes les années
   
Numéros anciens des Annales des Mines
1794-1914
1915-1943
Lois et réglementation
1919 – 1942
Articles

1946 – 1991

 

 

         
         
 

 

 

Télécharger gratuitement
la revue complète

 

  February 2017 - Industrial biology: the technological, economic and societal issues of biotechnology

Issue editor: Françoise ROURE,

Conseil général de l’économie (CGE)
and

Jean-Luc PUJOL,

Haut Conseil des biotechnologies (HCB)


To read summaries, click on the article titles


Editorial: Carlos MOEDAS,

European Commissioner of Research and Development

 

Foreword: Jean-Luc PUJOL,

Haut Conseil des biotechnologies (HCB)

et

Françoise ROURE,

Conseil général de l’économie (CGE)

 


The scientific, technical and innovative potentials

 

The knowledge necessary for industrial biology

Pierre Monsan,
president of the Fédération Française de Biotechnologie & founding chairman of the board of administration of Toulouse White Biotechnology

 

Big data in oncology: From basic research to applications in behalf of patients

Emmanuel Barillot,
director of INSERM laboratory 900 (Curie Institute),
and
Philippe Hupé,

assistant director of the bioinformatics platform at Curie Institute

 

Advanced metrology’s contribution to the assessment of medical-biological tests and the improvement of their reliability

Vincent Delatour,
expert in biomarkers, Laboratoire National de Métrologie et d’Essais (LNE)

 

Standardizing engineering techniques in biomedical research: Centers of biological resources

Bruno Clément,
director of the INSERM laboratory Nutrition, Metabolism and Cancer in Rennes & scientific director of Infrastructure Nationale Biobanques;
Paul Hofman,
professor of pathology at the Nice CHU;
Mireille Desille,
engineer at CRB-Santé, Rennes CHU;
and
Georges Dagher,
research director at INSERM & coordinator of Infrastructure Nationale Biobanques

 

The contribution of bioengineering to innovative applications: Materials of biological origin

François Ténégal,
managing director of the Institut Français des Matériaux Agro-Sourcés (IFMAS);
and
Patricia Krawczak,
professor at Institut Mines-Télécom (Mines Douai) & general secretary of the IFMAS Steering Committee on Strategy

 

New plant-breeding techniques: A few words from the world’s fourth seed company (Limagrain) on innovation in agriculture

Jean-Christophe Gouache,
director of International Affairs at Limagrain

 

Personalized medicine: How far? A research challenge for the pharmaceutical industry and its partners

Marc Bonnefoi,
vice-president of R&D, Sanofi France

 

Hydrocarbons produced by industrial biology: Global Bioenergies’ background and prospects

Marc Delcourt,
managing director of Global Bioenergies;
and
Ronan Rocle,
business manager

 

Modeling biological systems: A way to produce several forms of innovation

François Iris,
scientific director, founder and chairman of BMSystems;
and
Manuel Gea,
managing director, vice-president R&D and co-founder of BMSystems


The economic surge

 

Understanding value chains in industrial biotechnology

Jim Philp,
conseiller Biotechnologies à DSTI/OCDE,
Alain Schieb,
président de BACKCASTING SAS et consultant auprès de l’OCDE,
and
Mohamed Majdi Chelly,
ingénieur d’études à ENGIE Cofely France

 

Industrial bioeconomics at the regional level: The biorefinery at Bazancourt-Pomacle, a springboard for a territorial strategy

Maryline Thénot,
professor, head of the Finance Department, chair of Industrial Bioeconomics at NEOMA Business School;
and
Honorine Katir,
research engineer, chair of Industrial Bioeconomics at NEOMA Business School

 

Intellectual property and the maturity of innovations in industrial biology

Nathalie Mantrand-Foussadier,
senior consultant on chemistry and biotechnology, Questel Consulting

 

The map of industrial biology in France: Medical biotechnology

Gaëtan Poncelin de Raucourt,
chief engineer from École des Mines, head of the Health Industry Bureau (Direction générale des Entreprises, Ministry of the Economy and Finance)

 

The value of education and an education in values: Industrial biotechnology

Vanessa Proux,
managing director, Pôle de Compétitivité Medicen Paris Region and chair of Commission Formation;
and
Fabien Milanovic,
PhD in sociology from René Descartes University

 

Role of Nutritional Therapy in Healthcare Innovation: The Need for Reshaping Regulatory Paradigms

Manfred Ruthsatz,
PhD, Nestlé Health Science, Global Head of Regulatory Advocacy

 

Including microbiota in corporate strategies for research and innovation: The lessons drawn from MetaGenoPolis, a preindustrial demonstration project

Joël Doré,
PhD, research director at INRA and scientific director at MetaGenoPolis;
and
David Petiteau,
in charge of developing research through partnerships on Microbiome Programs at INRA


Toward a responsible industrial biology: Ethical and societal questions and controversies

 

The scope and limits of new plant-breeding techniques

Nils Braun
in change of biosecurity and safety, Haut Conseil des biotechnologies (Paris)

 

Microorganisms in the soil: Biological tools for reaching the objectives of sustainable development

Jean-Marc Châtaigner,
managing director of IRD;
and
Robin Duponnois,
director of the Laboratory of Tropical & Mediterranean Symbioses

 

New biotechniques: Ethical questions and the socioeconomic consequences on agriculture and biodiversity

Guy Kastler,

Confédération paysanne, a founding member of the network Semences paysannes

 

The misuse and malicious uses of the new biotechnologies

BrigGen (ret’d) Ioannis (John) Galatas,
MD, MA, MC (Army), Manager, CBRN Knowledge Center @ International CBRNE Institute (BE)

 

Genome-editing: A breakthrough technology

Hervé Chneiweiss,
neurologist, chairman of the Ethics Committee at INSERM


Miscellany

 

Additive manufacturing: Where are we?

Pascal Morand,
president of the Fédération de la Couture, du Prêt-à-Porter, des Couturiers et des Créateurs de Mode, member of the Academy of Technologies;
Joël Rosenberg,
head of innovation (Direction de la Stratégie, Ministry of Defense);
and
Dominique Turcq,
founding president of Boostzone Institute

 

 

 

 

 

 

Les Annales des Mines

Télédoc 797, 120, rue de Bercy – 75572 – Paris cedex 12
Courriel :
redactiondesannalesdesmines.cgeiet@finances.gouv.fr